Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components

v3.23.3
Balance Sheet Components
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Accounts Receivable, Net
Accounts receivable, net consisted of the following:
September 30, December 31,
2023 2022
(In thousands)
Trade receivables $ 12,697  $ 9,639 
Less: Allowances for credit losses (100) (454)
Total $ 12,597  $ 9,185 
Inventories
Inventories consisted of the following:
September 30, December 31,
2023 2022
(In thousands)
Raw materials $ 69,701  $ 58,585 
Work-in-progress 10,300  12,617 
Finished goods 1,158  — 
Total $ 81,159  $ 71,202 
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
September 30, December 31,
2023 2022
(In thousands)
Prepaid insurance and other $ 2,030  $ 3,316 
Vendor prepayments 485  2,217 
Total $ 2,515  $ 5,533 
Property and Equipment, Net
Property and equipment, net consisted of the following:
September 30, December 31,
2023 2022
(In thousands)
Computers and software $ 2,490  $ 2,222 
Lab equipment and other equipment 7,995  7,379 
Furniture and fixtures 246  181 
Leasehold improvements 16,060  16,273 
Total property, plant and equipment 26,791  26,055 
Less accumulated depreciation and amortization (9,361) (6,243)
Property, plant and equipment, net $ 17,430  $ 19,812 
Depreciation expense for the three months ended September 30, 2023 and 2022 was $1.5 million and $0.9 million, respectively. Depreciation expense for the nine months ended September 30, 2023 and 2022 was $3.8 million and $2.1 million, respectively.
The manufacturing facility operating lease at Campbell (McGlincy) was terminated on March 31, 2023, and is no longer in use. There were no significant asset retirement obligations. The Company wrote-off $0.6 million in fully-depreciated leasehold improvements related to the Campbell (McGlincy) lease during the nine months ended September 30, 2023.
Other Assets
Other assets consisted of the following:
September 30, December 31,
2023 2022
(In thousands)
Right of use assets $ 11,600  $ 13,545 
Net investments in sales-type lease 5,747  6,554 
Non-current prepaid expenses and other assets 4,435  3,211 
Total Other assets $ 21,782  $ 23,310 
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:
September 30, December 31,
2023 2022
(In thousands)
Accrued expenses $ 5,727  $ 8,602 
Accrued salaries and benefits 3,171  4,830 
Lease liability – current portion 2,317  2,445 
Total Accrued expenses and other current liabilities $ 11,215  $ 15,877 
Other Noncurrent Liabilities
Other noncurrent liabilities consisted of the following:
September 30, December 31,
2023 2022
(In thousands)
Lease liabilities – noncurrent portion $ 10,550  $ 12,206 
Other noncurrent liabilities 255  428 
Total other noncurrent liabilities $ 10,805  $ 12,634 
Please refer to Note 10, Equity Instruments, for further details of the contingent earnout liability and warrant liabilities.